---
$id: https://graph.org.ai/products/commodity/51102905
$type: Product
source: UNSPSC
code: "51102905"
title: "Amodiaquine and pyrimethamine/sulfadoxine"
class: "51102900"
classTitle: "Combination antimalarials"
family: "51100000"
familyTitle: "Amebicides and trichomonacides and antiprotozoals"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Amodiaquine and pyrimethamine/sulfadoxine

**UNSPSC Code**: 51102905
**Class**: [Combination antimalarials](Combination antimalarials.mdx)
**Family**: [Amebicides and trichomonacides and antiprotozoals](../Amebicides and trichomonacides and antiprotozoals.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This is a combination therapy used for seasonal malaria chemoprevention. The first component, AMODIAQUINE, has a US FDA Unique Ingredient Identifier of 220236ED28. The second component, PYRIMETHAMINE, has a US FDA Unique Ingredient Identifier of Z3614QOX8W. The third component, SULFADOXINE, has a US FDA Unique Ingredient Identifier of 88463U4SM5.

